The recent description of a T helper lymphocyte subset (Th17) that is characterized by the production of IL-17, TNF-, IL-6, IL-22, and GM-CSF has substantially influenced current concepts of the pathogenesis of inflammatory diseases such as arthritis or encephalitis. Contrasting with the prevailing dogma that held IFN-producing Th1 cells responsible for the pathogenesis of most organ-specific autoimmune diseases it had been noted for some time that IFN--/-mice were more susceptible to arthritis and encephalitis than their wild-type, littermates and that IL-12 was dispensable for disease induction. Recently it has become clear, that Th17 cells are of central importance for the pathogenesis of inflammatory diseases. The differentiation of naive Th cells into Th17 is triggered by antigen recognition in the presence of both IL-6 and TGF-. IL-23, a heterodimeric cytokine which shares the p40 chain with IL-12 is an important survival factor for Th17 whereas IL-27, another member of the IL-12 family strongly inhibits Th17 production. Here we review the protective and pathogenic functions of Th17 in host defense and inflammatory diseases.
INTRODUCTION
Cytokines produced by Th lymphocytes are critical for the regulation of both protective and pathogenic immune responses. An operational definition by which Th1 cells produce mostly IFN-and TNF-, whereas Th2 cells produce mainly IL-4, IL-5 and IL-13 [1] , has proven to be useful for the understanding of immune reactions in infectious, autoimmune, and allergic diseases [2] , although it is probably an oversimplification [3] . Th cells that produce cytokine patterns and exert functions distinct from the canonical Th1 or Th2 subsets include Th0 [4] , T FH [5] , and Treg [6, 7] . Most recently, a Th subset characterized by co-expression of IL-17 together with TNF-, GM-CSF, and lymphotactin but not Th1 or Th2 cytokines [8] has become the focus of attention. This pro-inflammatory subset of Th cells is important in murine models of host defence and also in the pathogenesis of chronic inflammatory diseases including arthritis [9] [10] [11] [12] [13] , encephalitis [14] [15] [16] [17] , colitis [18] [19] [20] [21] , myocarditis [22] , or asthma and allergy [23] [24] [25] [26] . A series of papers published within the past several months has demonstrated that IL-6 and TGF-are the crucial external triggers for the differentiation of naïve murine Th cells into these so-called Th17 cells [27] [28] [29] and that the transcription factor ROR t is necessary for Th17 differentiation [30] . The current knowledge on the differentiation of Th17 cells has recently been summarized in a series of excellent reviews [31] [32] [33] [34] [35] [36] . Here, we will focus on what is known about the protective and pathogenic functions of IL-17-producing Th cells in infections. Moreover, we will summarize the pathogenic effects of Th17 *Address correspondence to either author at the Institute of Immunology, College of Veterinary Medicine, University of Leipzig, D-04103 Leipzig, Germany; Tel: +49-341-9738328; Fax: +49-341-9738147; E-mail: alber@rz.uni-leipzig.de or Institute of Immunology, Medical Faculty, Friedrich-Schiller-Universität Jena, 07740 Jena, Germany; E-mail: immunologie@mti.uni-jena.de cells in inflammatory diseases (particularly arthritis) and point out several current gaps in knowledge.
IL-17 FAMILY MEMBERS
IL-17, then called CTLA-8, was originally cloned from murine T cell hybridoma cells [37] . The human ortholog was cloned shortly thereafter [38, 39] . IL-17 bears a striking similarity to a predicted open-reading frame, HSVS13, in the T-lymphotropic virus Herpesvirus saimiri [40] . Subsequently, five additional members of the IL-17 family (IL-17B-F) were discovered by homology based cloning [41] and IL-17 has been renamed IL-17A ( Table 1) . Within the IL-17 family, IL-17A shares the highest degree of sequence identity (55% and 40%, respectively) with the two isoforms of IL-17F which are also produced by Th cells [42] . Another family member, IL-17E, which is also called IL-25 is produced by Th2 cells in the mouse [43, 44] . In this review, we will focus on IL-17A.
Murine IL-17A is a 21-kDa glycoprotein consisting of 147 amino acids that is secreted as a disulfide-bonded dimer and shares 63% amino acid sequence homology with the 155-aa huIL-17A protein, but has no obvious homologies with cytokines outside the IL-17 familiy [41] . Similar to mRNAs encoding pro-inflammatory cytokines, both the human and murine IL-17A mRNAs possess several ATTTA motifs [37, 41] associated with rapid mRNA decay [45, 46] .
CELLULAR SOURCE OF IL-17 FAMILY MEMBERS
T lymphocytes are the only known source of secreted IL-17A ( Table 1) . In mice, IL-17A-producing Th cells are a distinct population which is different from Th1 or Th2 cells. They express IL-17 together with TNF-, GM-CSF, IL-6 and lymphotactin [8, [47] [48] [49] . Murine [50, 51] and human [52] CD8 + effector/memory cells can also produce IL-17. IL-17 has also been detected in murine T cells [53] . In addition, IL-17A message or protein have been reported in
IL-17 FUNCTIONS

Granulopoiesis, Neutrophil Recruitment and Activation
Perhaps the most prominent physiological function of IL-17A is the induction of granulopoiesis, activation and attraction of neutrophils towards inflammatory lesions [23, [65] [66] [67] [68] . IL-17A does not exert direct chemotactic effects on neutrophils (Fig. 1) . Instead, IL-17R-signaling induces or enhances the expression of G-CSF in parenchymal cells [38, [69] [70] [71] , CXCL8 (IL-8) [23, 38, 39, [72] [73] [74] [75] , and IL-6 [38-40, 73, 76] to generate, attract and activate neutrophils. The attraction of neutrophils puts IL-17A producing T cells at the interface between adaptive and innate immunity. Usually the innate immune response precedes and instructs the adaptive immune response and neutrophil influx is an early event in inflammation that precedes the effector functions of the adaptive immune response. Could IL-17, produced by CD4 + effector/memory cells relatively late in an inflammatory response substitute for an earlier innate neutrophil-attracting stimulus? Treatment of wild-type mice with IL-17 induced neutrophilia which depended on the presence of IL-6 [77] . An involvement of IL-17 in neutrophil infiltration was demonstrated in a model of contact hypersensitivity [78] . Neutrophil production was found to be regulated by the IL-23/IL-17 axis [53] . Phagocytosis of apoptotic neutrophils inhibits IL-23-dependent IL-17 synthesis. This regulatory pathway prevents mice from developing neutrophilia. Earlier evidence for a role of IL-23 in neutrophil production was provided by analyzing the number of peripheral neutrophils in IL-23 transgenic mice. A 3-to 11-fold increase of circulating neutrophils was found in IL-23p19-transgenic mice as compared with wild-type mice [79] . In addition, blood neutrophilia was associated with infiltration of neutrophils into various tissues. The recent observation that IL-23 supports IL-17 production [80] strongly suggests that the neutrophilia found in IL-23 transgenic mice can be correlated with IL-17.
IL-17 Induces Enhanced Expression of Proinflammatory Mediators
In addition to recruiting and activating neutrophils, IL-17A induces or enhances the release of cytokines, chemokines and other mediators of inflammation from parenchymal cells (Fig. 1) . This includes the induction of IL-6, leukemia inhibitory factor, PGE2 [38] , ICAM-1 [39, 81] , the complement components C3 and factor B [82] , matrix metalloproteinase expression [83] and IL-11 [55] in fibroblasts and other stromal cells [23, 38-40, 76, 84] , the induction of NO, iNOS, and cyclooxygenase-2 by chondrocytes [59, 85] . Furthermore, IL-17A can stimulate the production of both IL-1 and TNF-in murine but probably not in human monocytic cells [86, 87] .
IL-17 Modulates T-and B-Lymphocyte Functions
IL-17A seems to have an important, yet mechanistically ill understood, function in T-cell activation [24, 40, 78] . IL-17 is involved in allogeneic T cell proliferation [88] and is also required for allergen-specific Th cell activation in the sensitization period of the DTH [26, 78] . Moreover, IL-17 stimulation induces enhanced expression of the costimulatory molecule ICAM-1 on antigen-presenting cells, endothelial cells or target cells for cytotoxic T cells (Fig. 1) .
Currently it is not known exactly how IL-17A affects B cell function and antibody responses. However, both the IL-23 deficient and the IL-17A deficient mice have slightly [78, 89] .
TH17 CELLS
Definition and Differentiation of IL-17 Producing Th Cells
Originally it was shown that microbial products, including the TLR2 ligand outer surface protein A from the spirochete Borrelia burgdorferi or Mycobacterium bovis lysates act on antigen presenting cells which then induce naive Th cells to express IL-17 together with TNF-, GM-CSF and lymphotactin [8] . IL-17 producing Th cells were found at increased frequencies in the synovial fluids of patients with Lyme arthritis or Chlamydia-induced reactive arthritis [8] .
Later it was shown that IL-23, a member of the IL-12 family, supported the differentiation of IL-17-producing Th subset [31, 34, 80] . This was confirmed and extended by subsequent studies [47] [48] [49] and these cells were dubbed Th17. A common current definition of Th17 is that they produce IL-17, TNF-, and IL-6 but not IFN-or IL-4 [31, 34] . Recent research has shown that IL-22 is also co-expressed with IL-17 [90, 91] . IFN-should not be excluded from the Th17 profile since a significant proportion of the IL-17 producing Th cells, especially those at inflammatory effector sites in vivo co-express both IL-17 and IFN- [8, 92] although the Th17 are clearly different from Th1 cells (Fig. 2) .
TGF-and IL-6 are Differentiating Factors for Th17 Cells
Most recently it was shown that TGF-and IL-6 are necessary and sufficient to induce the differentiation of murine Th17 in vitro [27, 28, 93] . Depending on the experimental conditions, IL-18, IL-1 or TNF- [8, 27, 28, 93] were found to enhance the development of Th17. However, these cytokines cannot induce Th17 differentiation in the absence of IL-6 and TGF-. IL-4 or IFN-inhibit Th17-development ( Fig. 3) [8, 27, 28, 93] . In contrast, IL-17 does not influence Th1 or Th2 development [8, 21, 43, 94] . The differentiation of the murine Th17 lineage has been dealt with extensively in several recent reviews [32] [33] [34] 36] . Thus, we will not discuss this topic in detail. It should be noted, however, that it is currently unclear how IL-17 production is induced in human T cells.
The signal transduction pathways that enhance or inhibit Th17 differentiation are only beginning to be understood. Signaling molecules that are important for the differentiation of Th1 or Th2 cells, including STAT1, STAT4, and STAT6 are dispensable for the development of Th17 cells [47, 48] .
IL-23 which signals mainly through STAT3/4 heterodimers [95] supports Th17 differentiation or survival. STAT3 binds to the IL-17A and IL-17F promotors [96] . Very recently, the expression of IL-18R on APC was found to be essential for the generation of encephalitogenic Th17 cells in an EAE model [97] . Notably, IL-18 was dispensable for EAE development. The nature of the IL-18R ligand involved in Th17 development and EAE pathogenesis is currently unknown. ROR t is the transcriptional "master switch" for Th17 differentiation [30] , similar to T-bet for Th1 cells [98] , GATA-3 for Th2 [99] cells and FoxP3 for Tregs [100, 101] .
The exact cellular sources of IL-6 and TGF-for Th17 differentiation in vivo are not yet known and it is not known which, if any, infections preferentially induce TGF-. IL-6 is produced by DC in response to different pathogens and may inactivate Treg cells or prevent their differentiation [102] . It is therefore possible that chronic infection triggers the perpetuation of tissue inflammation by constantly providing a source of IL-6 which, in concert with the otherwise mainly anti-inflammatory TGF-, continually induces Th17 differentiation (Fig. 4) . Moreover, these findings do not exclude the possibility that TGF-producing Treg cells, when transferred into an IL-6 containing inflammatory environment might induce the differentiation of inflammatory Th17 cells. Clearly, the in vivo induction of Th17 needs to be understood more completely.
ROLE OF IL-23 IN TH17 DEVELOPMENT
IL-23 enhances the expression of both IL-17A and F [80] and is important for the proliferation or survival of Th17. Contrasting with earlier conclusions IL-23 is dispensable for the induction of Th17 [31] [32] [33] [34] . During development induced by IL-6 and TGF-, Th17 cells become responsive to IL-23, and IL-23 subsequently serves as a survival factor for committed Th17 cells [27, 28] . The latter finding provides a likely explanation for why IL-23 is required in vivo for Th17 cell-mediated diseases but is unable to promote Th17 cell differentiation in vitro. However, in some cases IL-23 can even be dispensable for IL-17 production but indispensable for protective immune responses. One example is the Citrobacter rodentium infection of mice mentioned above [28] .
In vivo studies demonstrated a crucial role for IL-23 rather than IL-12 in the pathogenesis chronic inflammatory diseases such as experimental autoimmune encephalitis (EAE) [103, 104] , and models of arthritis [105] , inflammatory bowel disease [18, [106] [107] [108] [109] , psoriasis [110] , or allergy [78, 89] (Table 2) . Collagen induced arthritis (CIA) is less severe in IL-23-deficient mice (IL-23p19 -/-mice) with fewer IL-17 producers than wild-type mice. In contrast, CIA is more severe in IL-12-deficient mice (IL-12p35 -/-mice) than in wild-type mice and the IL-12-deficient mice have more IL-17 producing Th cells than the wild-type mice [105] , suggesting that IL-23 enhances and IL-12 inhibits IL-17 expression and that IL-17A rather than IFN-is the major pathogenic cytokine.
In addition to supporting IL-17 production by Th17 cells, IL-23 has pathogenic effects in a model of inflammatory bowel disease by inducing IL-17 synthesis in non-T cells of the colon [106] .
Supporting Roles for IL-15 and IL-1 in Th17 Generation?
In contrast to the clearly Th17-enhancing function of IL-23, the role of IL-15 or IL-1 in the induction, expansion or survival of Th17 cells is much less clear. It has been suggested that IL-15 could enhance the IL-17 production of murine CD4 + cells [51] and that IL-15 produced by synoviocytes is a potent inducer of IL-17 production in RA patients [111] . However, the increased IL-17 production induced by IL-23 could not be inhibited by IL-15 blockade [80] .
Different experimental systems have yielded conflicting data on the enhancement of Th17 induction by IL-1 in vitro [8, 27, 28, 93] . One recent study found reduced IL-17 production in mice lacking the IL-1R. These mice were almost resistant to EAE-induction and their T cells produced little IL-17 when challenged with myelin antigens [112] .
Inhibition of Th17 Differentiation
Both Th1 and Th2 cells and their products inhibit Th17 differentiation. IL-17 production is inhibited by T-bet [113] and by IL-12 which signals mainly through STAT4. Th17 development is also inhibited by type I interferons and IFNwhich activate STAT1 resulting in the up-regulation of T-bet and the down-regulation of the IL-23R [47, 92] . IL-4 also blocks Th17 development [47] . In addition, IL-1Ra seems to have a role in inhibiting IL-17 production the mechanistic basis of which is currently unclear [24] .
SOCS3 is a major negative regulator of IL-6-induced and IL-23-induced STAT3 phosphorylation [96, 114] and there- fore inhibits IL-17 production. The IL-12 family member IL-27 induces SOCS3 in a STAT1-dependent way [115] and two recent papers [116, 117] have demonstrated that IL-27 is a potent inhibitor of Th17 development. Thus, a model emerges in which IL-27R signaling via STAT1 induces SOCS3 which then antagonizes the IL-17-inducing effects of IL-6 in Th cells.
Stability of Th17 Cells
Very little is known about the stability of Th17 responses. Th1 or Th2 cell lines have been maintained for several rounds of antigen stimulation and rested in vitro and their stability and plasticity has been studied in some detail [118, 119] . There is currently no published data on long-term Th17 lines. Thus, it is unclear if cytokine memory for IL-17 production exists and how it is established. It is also unclear if Th17 are short-lived effector cells or if they can be maintained as memory cells for extended periods of time in vitro or in vivo. The answers to these questions are necessary to understand the physiological and pathophysiological functions of Th17 responses and to design therapeutic strategies aiming at inhibiting unwanted and enhancing protective Th17 responses. To date, it is clear that IL-23 is important for the proliferation or survival of Th17 [31] [32] [33] [34] . The extent to which Th17 cells depend on IL-23 needs to be determined. In contrast to T cell survival factors such as IL-7 or IL-15, which are constitutively expressed, IL-23 is produced in response to inflammatory stimuli. It is therefore possible that the prolonged existence of Th17 depends on a continuous IL-23 supply (Fig. 4) . This could present an effective regulatory mechanism to prevent overshooting of chronic Th17 responses.
Exogenously added IL-18 or IL-6 also enhance the IL-17 production of murine Th cells [8, 32] . This is of interest because one of the major in vivo effects of IL-17 is the induction of IL-6, e.g. in rheumatoid synovial cells [23, [38] [39] [40] 76] . Furthermore, both TNF-and IFN-have additive ef- fects on the IL-17-induced expression of IL-6 [38] . The IL-17 mRNA is equipped with eight ATTTA motifs associated with rapid mRNA decay [37, 41] , which should normally prevent long-term effects of microbe-induced IL-17 [45, 46] . Chronic infection, e.g. with B. burgdorferi [120] , could maintain an IL-17-inducing stimulus. The reciprocal induction/enhancement of IL-17 and IL-6 could then contribute to the pathogenesis of chronic inflammatory diseases such as antibiotic-resistant Lyme arthritis [120] .
Protective Role of IL-17 and IL-23 in Antimicrobial Resistance
IL-23p19
-/-mice infected intratracheally with Klebsiella pneumoniae were recently shown to be more susceptible to infection than wild-type mice [121] . A functional link between the IL-23-dependent defect and IL-17 was convincingly made by administering IL-17 to infected IL-23p19 -/-mice [121] . In addition, IL-23p19 -/-and IL-17R -/-mice had similarly reduced survival rates upon infection with Klebsiella pneumoniae. This demonstrates that IL-23 protects mice in this infection model primarily via IL-17, most likely by promoting the expansion and survival of Th17 cells. Earlier, the same group had also shown that the increased susceptibility of IL-17R -/-mice infected with Klebsiella pneumoniae was associated with a significant delay in neutrophil recruitment into the alveolar space, reduced mRNA and protein levels of G-CSF and MIP-2 in the lung [65] . Very recently a protective role of IL-17 was also shown in Bordetella pertussis infection. Interestingly, IL-17 was found to activate macrophage killing of Bordetella pertussis [Higgins SC et al. J Immunol; in press].
In a murine infection model using the opportunistic fungal pathogen Cryptococcus neoformans IL-23p19 -/-mice showed a more subtle yet significant defect in protection [122] . In the absence of IL-23 infected mice had a moderately reduced survival time and delayed fungal clearance in the liver. This was accompanied by defective granuloma formation in the liver and an impaired inflammatory response in the brain. Antigen-specific IL-17 production by splenocytes was abrogated and expression of IL-1 , IL-6, and MCP-1 in the brain was impaired [122] . Similarly, in an aerosol model of infection with Mycobacterium tuberculosis defective IL-17 production was found in IL-23p19 -/-mice as compared to wild-type mice [123] . However, there was no phenotypic difference between wild-type and IL-23p19 -/-mice. In another study with Mycobacterium tuberculosisinfected mice IL-17 production was described primarily for T cells and other non-CD4 + CD8 + cells [124] . Also, in i.v.
Mycobacterium bovis BCG infection of wild-type and IL-23p19
-/-mice similar resistance was found [125] . Neutralization of IL-17A in the absence or presence of IL-12 did not increase susceptibility to Mycobacterium bovis BCG infection.
A protective role of IL-17A in experimental murine Candida albicans infection was reported [126] . Elevated fungal organ burden and reduced survival were associated with impaired mobilization of peripheral neutrophils and impaired and delayed neutrophil influx to infected organs.
Also, in acute infection with Toxoplasma gondii the protective function of IL-17 was accompanied by an optimal migration of neutrophils early on to the site of infection. Again, absence of IL-17 was found to be associated with decreased production of MIP-2 [127] .
A beneficial role of IL-17 has been found in CpGdependent protection during polymicrobial intraabdominal sepsis [128] .
Interestingly, in Citrobacter rodentium infection of mice IL-17 but not IL-23 was found to be dispensable for protection against this intestinal pathogen [28] . IL-23-deficient mice generated IL-17 responses similar to wild-type controls yet failed to clear the infection and died [28] . Thus, IL-17-independent IL-23 effects seem to be necessary for protective immunity against C. rodentium. For definitive analysis of the role of IL-17 in immunity to C. rodentium IL-17A-gene-deficient mice need to be infected with C. rodentium.
Taken together, the protective host defence responses initiated by IL-17A/F appear to rely largely on neutrophil (and potentially macrophage) activation. In addition, T-cell dependent type-IV hypersensitivity responses to some extent depend on IL-17 [78] and IL-23 [89] and may have their counterpart in IL-23/IL-17-dependent granuloma formation during host defense. Since IL-17 expression seems to be particularly high in intestinal lamina propria cells and mesenteric lymph nodes [32, 53] and IL-17 has been found to be important for the secretory activity and mucosal cell function [129] , mucosal immunity may be affected by IL-17. In fact IL-17 is up-regulated in Helicobacter pylori-infected human gastric mucosa leading to local expression of bioactive IL-8 [130] .
The mechanisms of host defence responses by IL-17E appear to be independent of neutrophil activation and recruitment. IL-17E (i.e. IL-25) plays an essential role in promoting protective Th2 responses against Trichuris muris [131] . In the murine Trichuris model IL-17E is protective by IL-5 and IL-13 induction and inhibition of IFN-and IL-17A. The latter mechanism limits pathological inflammation at the mucosal site. Also, IL-17E is required for efficient expulsion of Nippostrongylus brasiliensis and timely production of IL-5 and IL-13 [132] . 
Immunopathological Role of IL-17 and IL-23 in Murine Infection Models
A number of reports point to the involvement of IL-17 and/or IL-23 in infection-induced immunopathological phenomena.
In vitro, compelling evidence was provided for a link between microbial stimulation and IL-17 production together with GM-CSF and TNF-by CD4 + T cells [8] . This was found in a murine TCR-transgenic system following activation by lipopeptides from the causative agent of Lyme disease, Borrelia burgdorferi. Interestingly, IL-17 and TNFproducing Th cells could also be found in synovial fluid of patients with Lyme arthritis. Consistent with these data, IL-17 was shown in an experimental murine borreliosis model to contribute to arthritis in vaccinated IFN--/-mice challenged with Borrelia burgdorferi [133] . Treatment of mice with anti-IL-17 or with anti-IL-17 receptor antibody at the time of challenge prevented the development of arthritis.
In a model of abscess formation associated with intraabdominal sepsis IL-17 was demonstrated to be critical [134] . Upon challenge with Bacteroides fragilis IL-17 appeared to be produced by CD4 + T-cells within the abscess wall. Stimulation of CD4 + T cells was dependent on costimulation via the B7-CD28 pathway and on STAT4 signalling.
Intranasal LPS administration induces late phase (day 2) neutrophilic infiltration in lung associated with increased production of KC and MIP-2 [51] . IL-15 may be involved in LPS-induced and IL-17-dependent neutrophilia. In another study using LPS stimulation of airways IL-17, IL-6, and MIP-2 production led to neutrophil recruitment [68] . In addition, these authors showed that in vitro IL-17 induction from T cells needs co-culture with airway macrophages, and IL-6 and MIP-2 are from nonmacrophage/nonlymphocyte sources. In patients with cystic fibrosis who develop chronic Pseudomonas aeruginosa lung infection elevated levels of IL-23, IL-17A and IL-17F were found in the sputum [135] . Moreover, in a murine model of mucoid Pseudomonas aeruginosa lung infection IL-23 was found to enhance airway inflammation [136] . Thus, IL-23 could be a target for an anti-inflammatory therapy in cystic fibrosis.
Hepatic granulomatous inflammation is induced by eggs of Schistosoma mansoni and represents an immunopathological feature of the infection with Schistosoma mansoni in a pro-inflammatory environment. IL-12p35 -/-mice (unable to produce IL-12) but not IL-12p40 -/-mice (unable to produce IL-12 and IL-23) were susceptible for lesion development in liver and administration of neutralizing anti-IL-17 mAb inhibited hepatic granulomatous inflammation [137] . This points to the IL-23/IL-17 axis as the regulating mechanism which is responsible for the main pathology during infection with this helminth parasite.
IL-17 modulates the immune response to vaccinia virus. Infection of mice with vaccinia virus expressing IL-17 resulted in higher mortality, a decrease in NK cell cytotoxicity, altered virus-specific IgG and IgA antibody titers pointing to a Th2 pattern (reduction of IgG2a and induction of IgG1, IgG3 and IgA) [138] .
Pathogenic Effects of IL-17 in Inflammatory Diseases
Inappropriate IL-17 secretion causes pathology. IL-17A or IL-17-expressing cells have been associated with chronic inflammatory diseases [41] including rheumatoid arthritis [76] , multiple sclerosis [16, 17, 139] , inflammatory bowel disease [21] , skin- [140] and airway inflammation [23, 141] , autoimmune myocarditis [22, 142] , and transplant rejection [143] in humans ( Table 2) . Here, we will focus on the pathogenic role of IL-17A and IL-23 in arthritis and mention findings from other inflammatory diseases or disease models only briefly.
Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease primarily affecting the joints. Clinical and experimental evidence suggests that T cells are important in RA pathogenesis. IL-17 is expressed by CD45RO + CD4 + T lymphocytes in the rheumatoid but not in osteoarthritic synovia [76, 111, 144, 145] . High levels of IL-17A can be detected in the synovial fluid from RA patients [111, 144, 145] . Within the inflamed rheumatoid synovium, IL-17 is a major stimulus for the secretion of IL-6 by synoviocytes [144, 146] , although only 1% of synovial T cells were found to express IL-17 mRNA by in situ hybridization [144] . Similarly, approximately 2% of synovial fluid Th cells from patients with Lyme arthritis produced IL-17 upon polyclonal stimulation [8] . In addition to the pro-inflammatory effects mentioned above (section on IL-17 functions, Fig. 1 ) IL-17A has direct effects on cartilage and bone. IL-17 inhibits proteoglycan synthesis and induces proteoglycan breakdown [147] [148] [149] [150] [151] [152] , aggrecanase [150] and the expression of MMPs in synovial fibroblasts and osteoblasts [61, 83, [147] [148] [149] thus resulting in cartilage erosion and chondrocyte death [152] . Moreover, IL-17 is a potent stimulator of osteoclastogenesis [145] . These IL-17 effects are independent of IL-1 [150, 152] . Nevertheless, IL-17 acts synergistically with TNF- [153] and IL-1 [148] . The multiple effects of IL-17 in arthritis pathogenesis are summarized in Fig. 5 .
Mouse Models of Rheumatoid Arthritis
Given the pro-inflammatory, cartilage-and bonedegrading properties of IL-17A it is not surprising that IL-17 is critically important in the pathogenesis of several murine models of arthritis. The pathogenic T cells in glucose-6-phosphate-isomerase-induced arthritis produce IL-17, TNF-and IL-6 but very little if any IFN-or IL-4 [154, 155] . Similarly, the synovial fluid of arthritic SKG mice, which have a ZAP-70 mutation, contained high amounts of IL-6, TNF-, and IL-1. The Th cells of these mice were reported to be neither Th1, nor Th2 and large amounts of IL-17 mRNA were detected within the joints [156] .
Collagen induced arthritis (CIA) is less severe in IL-23 deficient mice (IL-23p19 -/-mice) than in wild-type littermates. Importantly the IL-23-deficient mice have more IFN-producing Th cells and fewer IL-17 producing Th cells than the wild-type controls. In contrast, the IL-12 deficient mice (IL-12p35 -/-) had more severe arthritis, more IL-17 and less IFN-producers than the wild-type littermates [105] .
Similar to the findings in arthritis patients, systemic IL-17A levels are rather low in CIA mice whereas IL-17 expression in the synovium is strongly increased [152] . Local overexpression of IL-17 within the joint results in more severe CIA and enhanced neutrophil influx [152] . The IL-17A-induced increase in RANKL expression further enhances bone erosion [157] .
Neutralization of IL-17 with antibodies or sIL-17R suppresses onset of CIA [152] or reduces the clinical severity of ongoing CIA [158] or antigen-induced arthritis [159] . Similarly, IL-17 neutralization ameliorates the chronic phase of antigen-induced arthritis [160] , streptococcal cell wall induced arthritis [12] and the destructive arthritis caused by B. burgdorferi in IFN-deficient mice [133] . CIA incidence and severity are markedly reduced but not completely suppressed in IL-17-deficient mice [161] . Thus, IL-17 is not absolutely required for the induction of CIA. Interestingly, these studies provided further evidence for an important function of IL-17 in T-cell priming [161] . The underlying mechanisms, however, remain obscure. IL-17A acts independently of IL-1 in murine models of arthritis. IL-1Ra-deficient mice spontaneously develop arthritis. This is completely inhibited if the IL-1Ra deficient mice are also IL-17-deficient [24] . In contrast, local overexpression of IL-17 induces a more severe destructive arthritis in IL-Ra deficient mice [162] .
Taken together, IL-17A is detectable in high amounts in the synovial membrane and synovial fluids from arthritis patients and IL-17A is critically important in the pathogenesis of all murine arthritis models thus far examined. The fact that IL-17 supports osteoclast development [163] is probably one important reason for its importance in arthritis pathogenesis.
Th17 in Humans and Therapeutic Perspectives
It is currently not known if a distinct Th17 lineage also exists in humans. IL-17-producing Th cells have also been demonstrated directly ex vivo in the synovial fluid of patients with Lyme arthritis or reactive arthritis. Similar to the murine Th17 lineage the majority of these cells co-expressed TNF-and GM-CSF. IL-17 and IFN-were co-expressed stochastically [8] . IL-17 producing T cell clones have been isolated from the synovial membranes and synovial fluid of rheumatoid arthritis patients. These have been described as Th1/Th0 [164] . IL-17 producing T cell lines from allergic patients were classified as both Th1 and Th2 cells [81] .
Its central importance for autoimmune inflammation in animal models makes IL-17 an interesting candidate for therapeutic intervention in chronic inflammatory diseases in man. Several preclinical studies have aimed at IL-17 and/or IL-23 as potential therapeutic targets (reviewed in [165] ). As with many interventions in autoimmune models [166] , prevention was much easier achieved than treatment. Thus, in an EAE model both anti-IL-23 and anti-IL-17 mAb were protective when given prior to disease onset, yet failed to influence acute disease when given therapeutically. However, relapses were reduced when anti-IL-17 treatment was administered during the course of EAE [92] . A recent series of papers described a novel approach of inhibiting IL-17-mediated immunopathology by immunizing experimental animals with IL-17A linked to a non-self protein or incorporated into virus like particles [142, [167] [168] [169] . This strategy showed in vivo efficacy in preventing EAE [167, 168] , arthritis [167] or myocarditis [142] . Although this approach is potentially very interesting, one needs to know more about the long-term side effects of inducing an anti-IL-17 immune response.
Finally, IL-17 blockade may have unwanted side-effects unrelated to infections. For example IL-17 seems to be involved in maintaining the integrity of mucosal barriers [170] .
Thus further preclinical studies are necessary to estimate the possible therapeutic efficacy and the safety of treatments aimed at blocking IL-17/IL-23 [92] .
CONCLUDING REMARKS AND OUTLOOK
Th17 cells are a subset of T helper lymphocytes that is crucial for the pathogenesis and modulation of inflammatory diseases. IL-6 and TGF-trigger for Th17 differentiation similar to IL-12 for Th1 and IL-4 for Th2 cells. IL-23 is an important survival factor for Th17 as is IL-2 for Treg. The transcriptional master switch for Th17 is now known to be ROR t -analogous to T-bet for Th1, GATA-3 for Th2 or FoxP3 for Treg. The central role of Th17 in inflammation could make them an attractive target for therapeutic intervention. Dampening Th17 responses might be feasible since the available data from IL-23 deficient (IL-23p19 -/-) or IL-17 deficient mice indicates that anti-infectious host responses are not fatally flawed in the absence of Th17. However, we do not know yet if Th17 cells do exist in humans. We also do not know about the longevity, stability and plasticity of these cells. Do Th17 memory cells exist? Or is Th17 a relatively short-lived effector population? The major physiological function of Th17, aside from inducing inflammation, remains to be further elucidated. As one of the major effects of Th17 is the induction of neutrophil mobilization and the major pathophysiological role of Th17 is in autoimmune inflammatory diseases one might ask if the role of neutrophils in these diseases merits reconsideration.
